Insulin Glulisine
Links shared publicly online about this topic
Insulin Glulisine Compared to Insulin Aspart and t... [Diabetes Technol Ther. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on April 7, 2011 at 3:45 am By:
Insulin Glulisine Compared to Aspart & Lispro Administered by CSII in Patients with Type 1 #Diabetes: RCT http://1.usa.gov/fX2sLy #hypoglyc
Temporary interruption in supply of Apidra (insulin glulisine): http://t.co/JlQoEj9
nelm.nhs.uk — “Temporary interruption in supply of Apidra (insulin glulisine): http://t.co/JlQoEj9” View full resource at nelm.nhs.uk
Most Recently Shared on September 12, 2011 at 9:58 am By:
Temporary interruption in supply of Apidra (insulin glulisine): http://t.co/JlQoEj9
Basal bolus insulin bested SSI therapy in surgery patients with type 2 diabetes
endocrinetoday.com — “When compared with sliding scale regular insulin, basal bolus treatment with insulin glargine plus insulin glulisine appeared superior in boosti” View full resource at endocrinetoday.com
Most Recently Shared on March 2, 2011 at 2:29 pm By:
Basal bolus insulin bested SSI therapy in surgery patients with type 2 diabetes http://bit.ly/eG9voh
Endocrinology Article | Pharmacokinetics
mdlinx.com — “Comparison of pharmacokinetic properties, physiochemical stability and pump compatibility of three rapid-acting insulin analogs: aspart, lispro and glulisine” View full resource at mdlinx.com
Most Recently Shared on December 10, 2010 at 5:27 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Comparison of pharmacokinetic properties, physiochemical stability and pump compatibility of three rapid-a... http://bit.ly/hAlHuC #endo
Less Glycemic Variability, Better Patient Reported Outcomes With Lantus & Apidra
medicalnewstoday.com — “Less Glycemic Variability, Better Patient Reported Outcomes With Lantus & Apidra” View full resource at medicalnewstoday.com
Most Recently Shared on June 28, 2010 at 6:30 pm By:
Scott Strumello Patient Expert
Less Glycemic Variability, Better Patient Reported Outcomes With Lantus & Apidra http://bit.ly/bEyOGc
Diabetes Mellitus, Type 2: eMedicine Endocrinology
emedicine.medscape.com — “Overview: Type 2 diabetes mellitus is a group of disorders characterized by hyperglycemia and associated with microvascular (ie, retinal, renal, possibly neuropathic), macrovascular (ie, coronary, peripheral vascular), and neuropathic (ie, autonomic, peripheral) complications. Unlike patients with type ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 5, 2010 at 6:29 pm By:
The genetics of type 2 diabetes are complex and not completely understood. Learn more about type 2 diabetes. http://bit.ly/pBZvf
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Ellen H Ullman
MSW, Activities Director @DayscapeFL, Dedicated to a cure for type 1 diabetes,VP @cwdfoundation,PEP Squad @diabetes_dri, quintessentially resourceful
-
MIMS Online
MIMS is the print and online prescribing database for all healthcare professionals.
-
Endocrine Today
The official Twitter for Endocrine Today, clinical news on diabetes and endocrine disorders.
Advertisement
